A new analysis of over 150,000 adults identifies a cohort who avoid the usual health risks of short sleep—and researchers say one lifestyle habit is the key to their resilience.

DARIEN, IL – A new clinical practice guideline from the American Academy of Sleep Medicine establishes evidence-based recommendations for the management of shift work disorder in adults. The guideline is published in the...

Most people stay relatively still while they sleep. However, some sleep disorders can cause a person to walk, move, or act out dreams without being fully awake. These behaviors can lead to falls, cuts, bruises, and other...

On Oct. 14, the Centers for Medicare & Medicaid Services shared important reminders about Quality Payment Program (QPP) deadlines, including those for exception applications and Merit-based Incentive Payment System (...

The acquisition of the national home sleep testing provider aims to bring EEG-enabled testing to primary care, telehealth, and specialty providers starting in 2027.

Drawing on data from the NIH's All of Us research program, researchers reveal a more comprehensive picture of the everyday challenges facing people with narcolepsy.

Preliminary findings from a phase 4 study highlight significant improvements in nighttime awakenings and vasomotor symptoms among menopausal women using the non-hormonal treatment fezolinetant.

Project Sleep CEO Julie Flygare shares her firsthand experience with Orzeyful and the questions she hopes clinicians will consider as the treatment enters clinical practice.

Data from 11 countries reveals consistent drops in deep sleep and increases in night-time heart rate during the premenstrual week, with US women recording the lowest sleep scores.

The newly available oral orexin receptor 2 agonist offers clinicians the first opportunity to prescribe a targeted treatment for underlying orexin deficiency in narcolepsy type 1, with a US rollout expected soon.